Patents by Inventor Kacy Stadtmiller

Kacy Stadtmiller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • RECOMBINANT POLYCLONAL PROTEINS TARGETING COVID-19 AND METHODS OF USE THEREOF
    Publication number: 20230287112
    Abstract: Provided herein are compositions comprising recombinant polyclonal proteins (RPPs) derived from mammalian plasma cells and plasmablasts. Also provided are methods of using the RPPs.
    Type: Application
    Filed: April 4, 2023
    Publication date: September 14, 2023
    Inventors: David Scott Johnson, Sheila Keating, Adam Shultz Adler, Michael Asensio, Kacy Stadtmiller, Emily Benzie, Ariel Niedecken, Angelica V. Medina-Cucurella, Rena Aviva Mizrahi, Yoong Wearn Lim
  • RECOMBINANT POLYCLONAL PROTEINS TARGETING ZIKA AND METHODS OF USE THEREOF
    Publication number: 20230265171
    Abstract: Provided herein are compositions comprising recombinant polyclonal protein (RPP) derived from mammalian plasma cells and plasmablasts. Specifically, RPPs specific to Zika virus are provided. Also provided are the methods of using the RPP for treatment of viral infection and the methods of making the RPPs.
    Type: Application
    Filed: April 27, 2023
    Publication date: August 24, 2023
    Inventors: David Scott JOHNSON, Sheila KEATING, Adam Shultz ADLER, Michael ASENSIO, Kacy STADTMILLER, Emily BENZIE, Ariel NIEDECKEN, Angelica V. Medina-Cucurella, Rena Aviva MIZRAHI, Yoong Wearn LIM
  • Recombinant polyclonal proteins targeting Zika and methods of use thereof
    Patent number: 11718660
    Abstract: Provided herein are compositions comprising recombinant polyclonal protein (RPP) derived from mammalian plasma cells and plasmablasts. Specifically, RPPs specific to Zika virus are provided. Also provided are the methods of using the RPP for treatment of viral infection and the methods of making the RPPs.
    Type: Grant
    Filed: September 8, 2021
    Date of Patent: August 8, 2023
    Assignee: GigaGen, Inc.
    Inventors: David Scott Johnson, Sheila Keating, Adam Shultz Adler, Michael Asensio, Kacy Stadtmiller, Emily Benzie, Ariel Niedecken, Angelica V. Medina-Cucurella, Rena Aviva Mizrahi, Yoong Wearn Lim
  • Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof
    Patent number: 11685779
    Abstract: Provided herein are compositions comprising recombinant polyclonal proteins (RPPs) derived from mammalian plasma cells and plasmablasts. Also provided are methods of using the RPPs.
    Type: Grant
    Filed: July 27, 2021
    Date of Patent: June 27, 2023
    Assignee: GigaGen, Inc.
    Inventors: David Scott Johnson, Sheila Keating, Adam Shultz Adler, Michael Asensio, Kacy Stadtmiller, Emily Benzie, Ariel Niedecken, Angelica V. Medina-Cucurella, Rena Aviva Mizrahi, Yoong Wearn Lim
  • RECOMBINANT POLYCLONAL PROTEINS TARGETING ZIKA AND METHODS OF USE THEREOF
    Publication number: 20220064268
    Abstract: Provided herein are compositions comprising recombinant polyclonal protein (RPP) derived from mammalian plasma cells and plasmablasts. Specifically, RPPs specific to Zika virus are provided. Also provided are the methods of using the RPP for treatment of viral infection and the methods of making the RPPs.
    Type: Application
    Filed: September 8, 2021
    Publication date: March 3, 2022
    Inventors: David Scott Johnson, Sheila Keating, Adam Shultz Adler, Michael Asensio, Kacy Stadtmiller, Emily Benzie, Ariel Niedecken, Angelica V. Medina-Cucurella, Rena Aviva Mizrahi, Yoong Wearn Lim
  • RECOMBINANT POLYCLONAL PROTEINS TARGETING COVID-19 AND METHODS OF USE THEREOF
    Publication number: 20220041715
    Abstract: Provided herein are compositions comprising recombinant polyclonal proteins (RPPs) derived from mammalian plasma cells and plasmablasts. Also provided are methods of using the RPPs.
    Type: Application
    Filed: July 27, 2021
    Publication date: February 10, 2022
    Inventors: David Scott Johnson, Sheila Keating, Adam Shultz Adler, Michael Asensio, Kacy Stadtmiller, Emily Benzie, Ariel Niedecken, Angelica V. Medina-Cucurella, Rena Aviva Mizrahi, Yoong Wearn Lim